| Completed | Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-0 Skin Diseases, Infectious, Skin Diseases, Bacterial | Phase 3 | 2015-03-25 |
| Completed | Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7 Critically Ill, Pneumonia | Phase 1 | 2015-02-05 |
| Completed | Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairme Healthy Volunteers, Renal Impairment | Phase 1 | 2014-12-11 |
| Completed | Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Ther Proven or Suspected Gram-negative Bacterial Infection, Peri-operative Prophylaxis | Phase 1 | 2014-09-17 |
| Completed | Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008) Healthcare-Associated Pneumonia, Ventilator-Associated Pneumonia, Lung Diseases | Phase 3 | 2014-09-02 |
| Completed | Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002) Pneumonia | Phase 3 | 2014-01-06 |
| Completed | Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hem Acute Hematogenous Osteomyelitis | Phase 3 | 2013-09-13 |
| Terminated | Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment Renal Impairment | Phase 1 | 2013-09-01 |
| Terminated | The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation Opioid-Induced Constipation | Phase 3 | 2013-07-02 |
| Terminated | Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneum Ventilator-Associated Pneumonia (VAP) | Phase 3 | 2013-06-14 |
| Terminated | Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation Opioid-Induced Constipation | Phase 3 | 2013-05-20 |
| Terminated | Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation Opioid-Induced Constipation | Phase 3 | 2013-04-07 |
| Completed | Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus B Bacteremia | Phase 4 | 2012-11-29 |
| Terminated | Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation Opioid-Induced Constipation | Phase 3 | 2012-10-12 |
| Completed | A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006) Clostridium Difficile Infection | Phase 3 | 2012-05-16 |
| Completed | Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) Clostridium Difficile Infection | Phase 3 | 2012-05-16 |
| Completed | Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraa Complicated Intra-abdominal Infection | Phase 3 | 2011-12-23 |
| Completed | Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA Staphylococcal Skin Infections | Phase 4 | 2011-09-09 |
| Completed | Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Uri Complicated Urinary Tract Infection, Pyelonephritis | Phase 3 | 2011-06-20 |
| Completed | Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation i Constipation | Phase 2 | 2011-01-19 |
| Completed | Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Ta Opioid Induced Constipation | Phase 2 | 2010-10-14 |
| Terminated | Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Complicated Skin or Skin Structure Infection | Phase 4 | 2010-07-15 |
| Completed | Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Int Complicated Intra-abdominal Infection | Phase 2 | 2010-06-25 |
| Completed | Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Healthy | Phase 1 | 2010-06-01 |
| Terminated | Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bactere Complicated Skin and Skin Structure Infections, S. Aureus Bacteremia, Renal Impairment | Phase 4 | 2010-04-19 |
| Completed | Study of CB-183,315 in Participants With Clostridium Difficile Infection Clostridium Difficile Infection, Diarrhea | Phase 2 | 2010-04-01 |
| Completed | Clinical Outcomes After Bowel Resection in Patients Receiving Alvimopan Versus Patients Not Receiving Alvimopa Ileus | — | 2010-04-01 |
| Completed | Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspecte Gram Positive Bacterial Infection | Phase 1 | 2010-01-05 |
| Terminated | Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia Postherpetic Neuralgia | Phase 2 | 2010-01-01 |
| Completed | Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of th Osteoarthritis of the Knee | Phase 2 | 2009-10-01 |
| Completed | Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections Complicated Urinary Tract Infection | Phase 2 | 2009-06-30 |
| Completed | Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subject Bloodloss, Surgical Procedures, Operative | Phase 2 | 2009-06-01 |
| Completed | Study to Evaluate Daptomycin Given During Dialysis and After Dialysis End-stage Renal Disease, Renal Failure Chronic Requiring Hemodialysis | Phase 1 | 2009-04-29 |
| Completed | A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy Postoperative Ileus | Phase 4 | 2009-03-01 |
| Completed | A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume Bloodloss, Surgical Procedures, Operative | Phase 2 | 2009-03-01 |
| Terminated | Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endo Infective Endocarditis | Phase 4 | 2009-02-13 |
| Terminated | Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA B Endocarditis, Bacterial, Infective Endocarditis | Phase 2 | 2008-09-17 |
| Completed | Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Struc Skin Diseases, Infectious | Phase 4 | 2008-07-23 |
| Completed | PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections Gram Positive Infection, Concurrent Antibiotic Treatment | Phase 1 | 2008-06-03 |
| Completed | Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Peripheral Neuropathy, Neuropathic Pain | Phase 2 | 2007-11-01 |
| Completed | Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2007-10-01 |
| Completed | Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambula End-Stage Renal Disease | Phase 1 | 2007-08-12 |
| Completed | Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Ca Osteomyelitis | Phase 2 | 2007-06-26 |
| Completed | Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar Extraction Acute Pain | Phase 2 | 2007-06-01 |
| Terminated | Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafti Blood Loss, Surgical | Phase 2 | 2007-05-01 |
| Completed | Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections Soft Tissue Infections | Phase 2 | 2007-01-01 |
| Terminated | Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid Cancer, Constipation | Phase 2 | 2006-04-01 |
| Completed | Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas Cellulitis | Phase 4 | 2006-02-20 |
| Completed | Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receivin Gram-positive Bacterial Infections | Phase 1 | 2005-08-24 |
| Completed | Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Bowel Dysfunction, Constipation | Phase 3 | 2005-08-01 |
| Completed | Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain Bowel Dysfunction, Constipation | Phase 3 | 2005-08-01 |
| Completed | Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain Bowel Dysfunction, Constipation | Phase 3 | 2005-08-01 |
| Terminated | Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infec Soft Tissue Infections | Phase 4 | 2005-01-01 |
| Completed | Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain S Cancer, Bowel Dysfunction | Phase 2 | 2004-09-01 |
| Completed | Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus Ileus | Phase 3 | 2004-06-01 |
| Terminated | Cubicin(R) for Complicated Post-surgical Wound Infections Wound Infections | Phase 4 | 2004-06-01 |
| Completed | Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication Constipation, Bowel Dysfunction | Phase 2 | 2003-10-01 |
| Terminated | Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria Gram-Positive Bacterial Infections | Phase 3 | 2002-12-19 |
| Completed | Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus Bacterial Endocarditis, Bacteremia | Phase 3 | 2002-03-01 |
| Completed | Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus Ileus | Phase 3 | 2002-01-01 |
| Completed | Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus Ileus | Phase 3 | 2001-12-01 |
| Completed | Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acq Pneumonia, Bacterial | Phase 3 | 2001-07-30 |
| Completed | Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus Ileus | Phase 3 | 2001-03-01 |
| Completed | Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe C Pneumonia, Bacterial | Phase 3 | 2000-10-31 |
| Terminated | HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection Hepatitis B, Liver Transplantation | Phase 2 | — |